Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00648973 · ClinicalTrials.gov registry record · Phase 4
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
A Phase 4 study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,021
- Enrollment target
NCT00648973 is a Phase 4 study that has completed, run by Johnson & Johnson Consumer and Personal Products Worldwide. The registered enrollment target is 1,021 participants.
The verdict
NCT00648973, a Phase 4 study, has completed, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,021 participants
- Enrollment target
Study Summary
The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.
Interventions
- DRUG Diphenhydramine 25 mg
- DRUG Diphenhydramine 50 mg
- DRUG Pseudoephedrine 120 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,021 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00648973
The ClinicalTrials.gov registry entry for NCT00648973 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,021 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Diphenhydramine 25 mg is the first listed.
NCT00648973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00648973 about?
NCT00648973 is a clinical study titled "To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses". The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.
What is the current status of trial NCT00648973?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,021 participants. The study started on 2006-11. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00648973?
The interventions under investigation include: Diphenhydramine 25 mg (DRUG), Diphenhydramine 50 mg (DRUG), Pseudoephedrine 120 mg (DRUG).
Who is sponsoring clinical trial NCT00648973?
This trial is sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.